BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27784973)

  • 1. Contrast-enhanced ultrasonography in the evaluation of incidental focal liver lesions: A cost-effectiveness analysis.
    Smajerova M; Petrasova H; Little J; Ovesna P; Andrasina T; Valek V; Nemcova E; Miklosova B
    World J Gastroenterol; 2016 Oct; 22(38):8605-8614. PubMed ID: 27784973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis.
    Westwood M; Joore M; Grutters J; Redekop K; Armstrong N; Lee K; Gloy V; Raatz H; Misso K; Severens J; Kleijnen J
    Health Technol Assess; 2013 Apr; 17(16):1-243. PubMed ID: 23611316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-enhanced ultrasound (CEUS) has excellent diagnostic accuracy in differentiating focal liver lesions: results from a Swiss tertiary gastroenterological centre.
    Sawatzki M; Meyenberger C; Brand S; Semela D
    Swiss Med Wkly; 2019 Jun; 149():w20087. PubMed ID: 31256416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-enhanced ultrasound (CEUS) for the evaluation of focal liver lesions - a prospective multicenter study of its usefulness in clinical practice.
    Sporea I; Badea R; Popescu A; Spârchez Z; Sirli RL; Dănilă M; Săndulescu L; Bota S; Calescu DP; Nedelcu D; Brisc C; Ciobâca L; Gheorghe L; Socaciu M; Martie A; Ioaniţescu S; Tamas A; Streba CT; Iordache M; Simionov I; Jinga M; Anghel A; Cijevschi Prelipcean C; Mihai C; Stanciu SM; Stoicescu D; Dumitru E; Pietrareanu C; Bartos D; Manzat Saplacan R; Pârvulescu I; Vădan R; Smira G; Tuţă L; Săftoiu A
    Ultraschall Med; 2014 Jun; 35(3):259-66. PubMed ID: 24563420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of CEUS in the differential diagnosis of small (≤ 20  mm) and subcentimetric (≤ 10  mm) focal liver lesions in comparison with histology. Results of the DEGUM multicenter trial.
    Strobel D; Bernatik T; Blank W; Schuler A; Greis C; Dietrich CF; Seitz K
    Ultraschall Med; 2011 Dec; 32(6):593-7. PubMed ID: 22161556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How useful is contrast enhanced ultrasonography for the characterization of focal liver lesions?
    Sporea I; Sirli R; Martie A; Popescu A; Danila M
    J Gastrointestin Liver Dis; 2010 Dec; 19(4):393-8. PubMed ID: 21188330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-enhanced ultrasound can guide the therapeutic strategy by improving the detection of colorectal liver metastases.
    Sawatzki M; Güller U; Güsewell S; Husarik DB; Semela D; Brand S
    J Hepatol; 2021 Feb; 74(2):419-427. PubMed ID: 33065168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of contrast-enhanced ultrasound in differentiating benign and malignant focal liver lesions: a retrospective study.
    Ooi CC; Low SC; Schneider-Kolsky M; Lombardo P; Lim SY; Abu Bakar R; Lo RH
    J Med Imaging Radiat Oncol; 2010 Oct; 54(5):421-30. PubMed ID: 20958940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective Analysis of Contrast-enhanced Ultrasonography Effectiveness in Reducing Time to Diagnosis and Imaging-related Expenditures at a Single Large United States County Hospital.
    Streb JW; Tchelepi H; Malhi H; Deurdulian C; Grant EG
    Ultrasound Q; 2019 Jun; 35(2):99-102. PubMed ID: 30169489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indeterminate focal liver lesions incidentally discovered at gray-scale US: role of contrast-enhanced sonography.
    Bartolotta TV; Taibbi A; Midiri M; Matranga D; Solbiati L; Lagalla R
    Invest Radiol; 2011 Feb; 46(2):106-15. PubMed ID: 20938345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of Sonazoid-enhanced ultrasonography in characterizing indeterminate focal liver lesions on gadoxetic acid-enhanced liver MRI in patients without risk factors for hepatocellular carcinoma.
    Ban JY; Kang TW; Jeong WK; Lee MW; Park B; Song KD
    PLoS One; 2024; 19(5):e0304352. PubMed ID: 38787832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-enhanced ultrasound: Improving the preoperative staging of hepatocellular carcinoma and guiding individual treatment.
    Zhang XY; Luo Y; Wen TF; Jiang L; Li C; Zhong XF; Zhang JY; Ling WW; Yan LN; Zeng Y; Wu H
    World J Gastroenterol; 2014 Sep; 20(35):12628-36. PubMed ID: 25253968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic assessment of contrast-enhanced ultrasonography for evaluation of focal liver lesions: a multicentre Italian experience.
    Romanini L; Passamonti M; Aiani L; Cabassa P; Raieli G; Montermini I; Martegani A; Grazioli L; Calliada F
    Eur Radiol; 2007 Dec; 17 Suppl 6():F99-106. PubMed ID: 18376463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical value of contrast-enhanced ultrasonography in the characterization of focal liver lesions: a prospective multicenter trial.
    Wang WP; Wu Y; Luo Y; Li R; Zhou XD; Zhang J; Qian CW; Tan XY; Xu QH; Wang Y; Yuan JJ
    Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):370-6. PubMed ID: 19666405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast enhanced ultrasound in focal liver lesions--a cost efficiency study.
    Sirli R; Sporea I; Martie A; Popescu A; Dănilă M
    Med Ultrason; 2010 Dec; 12(4):280-5. PubMed ID: 21210012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of computed tomography (CT), magnetic resonance imaging (MRI) and contrast-enhanced ultrasound (CEUS) in the evaluation of unclear renal lesions.
    Marschner CA; Ruebenthaler J; Schwarze V; Negrão de Figueiredo G; Zhang L; Clevert DA
    Rofo; 2020 Nov; 192(11):1053-1059. PubMed ID: 32294790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-Enhanced Ultrasound for the Characterization of Malignant versus Benign Focal Liver Lesions in a Prospective Multicenter Experience - The SRUMB Study.
    Sporea I; Săndulescu DL; Şirli R; Popescu A; Danilă M; Spârchez Z; Mihai C; Ioanițescu S; Moga T; Timar B; Brisc C; Nedelcu D; Săftoiu A; Enăchescu V; Badea R
    J Gastrointestin Liver Dis; 2019 Jun; 28():191-196. PubMed ID: 31204417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of focal liver lesions undetermined at grey-scale US: contrast-enhanced US versus 64-row MDCT and MRI with liver-specific contrast agent.
    Bartolotta TV; Taibbi A; Midiri M; La Grutta L; De Maria M; Lagalla R
    Radiol Med; 2010 Aug; 115(5):714-31. PubMed ID: 20082225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can contrast-enhanced ultrasonography characterize focal liver lesions and differentiate between benign and malignant, thus providing a one-stop imaging service for patients?().
    Cokkinos DD; Blomley MJ; Harvey CJ; Lim A; Cunningham C; Cosgrove DO
    J Ultrasound; 2007 Dec; 10(4):186-93. PubMed ID: 23396623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal liver lesions in cirrhosis: value of contrast-enhanced ultrasonography compared with Doppler ultrasound and alpha-fetoprotein levels.
    D'Onofrio M; Faccioli N; Zamboni G; Malagò R; Caffarri S; Fattovich G; Mucelli RP
    Radiol Med; 2008 Oct; 113(7):978-91. PubMed ID: 18779929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.